跳到正文
心血管健康随机对照试验3 分钟阅读

英国试验:家庭自测血压用于调药,收缩压更低

MoveVitals 编辑部 · 研究发表 · 解读更新

原文:Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. · Lancet (London, England) · 2018 · 论文原文 ↗

先看重点

在1182名血压控制不佳的英国成年人中,使用家庭自测血压来指导调药,12个月时收缩压与常规诊疗相比的差值为-3.5 mm Hg(95%置信区间-5.8至-1.2),加上远程监测则为-4.7 mm Hg(95%置信区间-7.0至-2.4)。试验为非盲设计,主要分析缺失15%的参与者,资助方之一是血压计厂商。

证据类型

随机对照试验

解读依据

公开摘要

阅读重点

对照与不确定性

研究在问什么

以往关于用自测血压来调整降压药的试验结果相互矛盾,远程监测相比单纯自测是否有额外价值也不清楚。TASMINH4试验想检验在基层医疗中,自测血压联合或不联合远程监测用于调药,与常规诊疗相比效果如何。

研究了谁,如何研究

在英国142家全科诊所进行的平行、非盲随机对照试验。纳入年龄大于35岁、血压高于140/90 mm Hg且愿意自测血压的成年人,通过安全的网络系统按1:1:1随机分入自测血压组(n=395)、自测加远程监测组(n=393)或以诊室血压为依据的常规诊疗组(n=394)。主要结局为12个月时诊室测量的收缩压。主要分析采用可获得的病例(1003人,85%),敏感性分析使用多重插补。

主要发现

以下为作者报告的结果。数字须连同人群和不确定性一起阅读。

  1. 1
    12个月时,自测组平均收缩压为137.0 mm Hg(SD 16.7),远程监测组为136.0 mm Hg(SD 16.1),常规诊疗组为140.4 mm Hg(SD 16.5)。
  2. 2
    与常规诊疗相比,校正后的平均差值在单纯自测组为-3.5 mm Hg(95%置信区间-5.8至-1.2),在远程监测组为-4.7 mm Hg(95%置信区间-7.0至-2.4)。
  3. 3
    自测组与远程监测组之间差异不显著(校正后平均差值-1.2 mm Hg,95%置信区间-3.5至1.2)。
  4. 4
    使用多重插补的敏感性分析结果相似,三组不良事件相近。

局限与不确定性

  1. 1
    参与者和研究者均未设盲,这可能影响血压管理和结果记录。
  2. 2
    1182名参与者中只有1003人(85%)纳入主要分析,约15%没有12个月时的结果。
  3. 3
    参与者需愿意自测血压,因此结果未必适用于不愿意自测的人。
  4. 4
    资助方包括家用血压计厂商Omron Healthcare UK,本解读仅基于摘要。

对日常健康的启示

由医生根据家庭血压读数调整药物,比仅依靠诊室读数多带来了幅度不大但确实存在的降压效果,而且通过远程监测传送读数并不明显优于在诊所查看。不要根据家庭读数自行改药;这里的获益来自医生据此行动,请与医生商量自测血压的做法。

如何联系自己的数据

合适的工具是经过验证的上臂式家用血压计:在固定时间、坐姿休息后测量,记录读数并提供平均值,而不是单次数值。能估测血压的腕戴手表不在本试验的测试范围内。

如何理解这类证据

随机分组有助于因果推断,仍须检查分配、盲法、失访、随访时间和具体对照;标为随机试验不自动意味着高确定性。

作者的结构化摘要 English

以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。

Background

Studies evaluating titration of antihypertensive medication using self-monitoring give contradictory findings and the precise place of telemonitoring over self-monitoring alone is unclear. The TASMINH4 trial aimed to assess the efficacy of self-monitored blood pressure, with or without telemonitoring, for antihypertensive titration in primary care, compared with usual care.

Methods

This study was a parallel randomised controlled trial done in 142 general practices in the UK, and included hypertensive patients older than 35 years, with blood pressure higher than 140/90 mm Hg, who were willing to self-monitor their blood pressure. Patients were randomly assigned (1:1:1) to self-monitoring blood pressure (self-montoring group), to self-monitoring blood pressure with telemonitoring (telemonitoring group), or to usual care (clinic blood pressure; usual care group). Randomisation was by a secure web-based system. Neither participants nor investigators were masked to group assignment. The primary outcome was clinic measured systolic blood pressure at 12 months from randomisation. Primary analysis was of available cases. The trial is registered with ISRCTN, number ISRCTN 83571366.

Findings

1182 participants were randomly assigned to the self-monitoring group (n=395), the telemonitoring group (n=393), or the usual care group (n=394), of whom 1003 (85%) were included in the primary analysis. After 12 months, systolic blood pressure was lower in both intervention groups compared with usual care (self-monitoring, 137·0 [SD 16·7] mm Hg and telemonitoring, 136·0 [16·1] mm Hg vs usual care, 140·4 [16·5]; adjusted mean differences vs usual care: self-monitoring alone, -3·5 mm Hg [95% CI -5·8 to -1·2]; telemonitoring, -4·7 mm Hg [-7·0 to -2·4]). No difference between the self-monitoring and telemonitoring groups was recorded (adjusted mean difference -1·2 mm Hg [95% CI -3·5 to 1·2]). Results were similar in sensitivity analyses including multiple imputation. Adverse events were similar between all three groups.

Interpretation

Self-monitoring, with or without telemonitoring, when used by general practitioners to titrate antihypertensive medication in individuals with poorly controlled blood pressure, leads to significantly lower blood pressure than titration guided by clinic readings. With most general practitioners and many patients using self-monitoring, it could become the cornerstone of hypertension management in primary care.

Funding

National Institute for Health Research via Programme Grant for Applied Health Research (RP-PG-1209-10051), Professorship to RJM (NIHR-RP-R2-12-015), Oxford Collaboration for Leadership in Applied Health Research and Care, and Omron Healthcare UK.

来源与署名

Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial.

McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, Bradburn P, Farmer A, Grant S, Greenfield SM, Heneghan C, Jowett S, Martin U, Milner S, Monahan M, Mort S, Ogburn E, Perera-Salazar R, Shah SA, Yu LM, Tarassenko L, Hobbs FDR, TASMINH4 investigators.

Lancet (London, England) · 2018-02-27

DOI: 10.1016/s0140-6736(18)30309-x ↗PubMed · 29499873 ↗Europe PMC · 记录的开放许可: cc by ↗

摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。

MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅

来源核验日期 2026-11-01

实用健康指南

放在一起读

·观察研究荟萃分析

昼夜活动节律紊乱与更高的死亡风险相关(109,365人)

在7项观察性研究、共109,365名参与者中,昼夜活动对比较弱(相对振幅较低)与更高的心血管死亡风险(风险比[HR]1.50,95%置信区间1.13至1.98)和全因死亡风险(HR 1.46,95%置信区间1.27至1.68)相关。证据基础小,又是观察性的,不能说明改善节律就能降低风险,疾病本身也可能扰乱节律。

Journal of the American Heart Association

重点论文精讲阅读论文 →
·随机试验荟萃分析

五类运动都降低了静息血压,等长训练降幅最大

汇总270项随机试验、共15,827名参与者的结果,有氧、抗阻、联合、间歇和等长训练与无干预对照组相比都降低了静息血压(各P<0.001),其中等长训练降幅最大:收缩压下降8.24 mm Hg,舒张压下降4.00 mm Hg。各方式之间的排序部分来自间接比较,各试验也不尽相同,所以排序不是个人的运动处方。

British Journal of Sports Medicine

重点论文精讲阅读论文 →
·随机对照试验

盐替代品使中国农村高危人群的卒中、主要心血管事件和死亡率下降

在中国农村600个村庄、20,995名有卒中史或年龄在60岁及以上且有高血压的人中,使用盐替代品(氯化钠75%、氯化钾25%)的卒中发生率低于普通盐:平均随访4.74年,每1000人年29.14次对33.65次(率比0.86,95%置信区间0.77至0.96;P=0.006)。死亡也更低(率比0.88),严重高钾血症事件没有显著增多,但试验为开放标签设计,且在中国农村开展。

The New England Journal of Medicine

重点论文精讲阅读论文 →
·测量验证研究/综述

智能手表脉搏不规则提醒较少见,做贴片检查者34%确有房颤

在419,297名没有已知心房颤动(房颤)的苹果手表用户中,0.52%收到脉搏不规则提醒;返还可用心电贴片的450人中,34%确认有房颤(97.5%置信区间29至39)。提醒发出时恰有贴片记录的,通知的阳性预测值为0.84(95%置信区间0.76至0.92),但收到提醒者中仅20.8%返还了贴片,没有收到提醒的人未被监测,所以手表没有提醒并不能排除房颤。

The New England Journal of Medicine

重点论文精讲阅读论文 →
心血管健康 →